Axicabtagene ciloleucel,Cyclophosphamide,Fludarabine
gilead
['zuma-7', 'lymphoma', 'lymsm']
 the zuma-7 trial is the first in nearly 30 years to significantly improve overall survival in patients with large b-cell lymphoma in 2l treatment. read more: #asco23 #lymsm 
Director of Clinical Research, Section Chief Aggressive Lymphoma @MDAndersonNews, @ASCO Assoc Board Treasurer & Govt Relations Committee Chair, Opinions mine